Personal tools

Coexpression cluster:C154: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0006826!iron ion transport!0.031978858554635!4891;53940
|gostat_on_coexpression_clusters=GO:0006826!iron ion transport!0.031978858554635!4891;53940
|id=C154
|id=C154
|ontology_enrichment_celltype=CL:0000187!6.43e-13!54;CL:0000680!6.88e-13!57;CL:0000056!6.88e-13!57;CL:0000355!6.88e-13!57;CL:0000393!9.51e-13!60;CL:0000211!9.51e-13!60;CL:0000183!5.90e-12!59;CL:0000192!2.64e-09!42;CL:0000514!2.64e-09!42;CL:0000055!1.86e-08!180
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000481!2.22e-26!347;UBERON:0003104!4.85e-23!238;UBERON:0009142!4.85e-23!238;UBERON:0005256!2.42e-20!143;UBERON:0002100!8.74e-19!216;UBERON:0001007!4.40e-16!155;UBERON:0001555!4.40e-16!155;UBERON:0007026!4.40e-16!155;UBERON:0004119!1.68e-15!169;UBERON:0000925!1.68e-15!169;UBERON:0006595!1.68e-15!169;UBERON:0002385!7.85e-14!63;UBERON:0001015!7.85e-14!63;UBERON:0000383!7.85e-14!63;UBERON:0000914!7.88e-14!83;UBERON:0002329!7.88e-14!83;UBERON:0003077!7.88e-14!83;UBERON:0003059!7.88e-14!83;UBERON:0007282!7.88e-14!83;UBERON:0009618!7.88e-14!83;UBERON:0007285!7.88e-14!83;UBERON:0000477!1.09e-13!286;UBERON:0000922!1.77e-13!612;UBERON:0001134!6.18e-13!61;UBERON:0002036!6.18e-13!61;UBERON:0003082!6.18e-13!61;UBERON:0004921!9.19e-13!129;UBERON:0004185!9.19e-13!129;UBERON:0000490!9.85e-13!138;UBERON:0004290!1.04e-12!70;UBERON:0000483!1.17e-12!309;UBERON:0002050!1.54e-12!605;UBERON:0005423!1.54e-12!605;UBERON:0000119!3.20e-12!312;UBERON:0000923!3.58e-12!604;UBERON:0005291!3.58e-12!604;UBERON:0006598!3.58e-12!604;UBERON:0002532!3.58e-12!604;UBERON:0000468!4.21e-12!659;UBERON:0000475!5.20e-12!365;UBERON:0000926!8.52e-12!448;UBERON:0004120!8.52e-12!448;UBERON:0006603!8.52e-12!448;UBERON:0000077!1.45e-11!130;UBERON:0000480!5.51e-11!626;UBERON:0004111!8.27e-11!241;UBERON:0000467!1.00e-10!625;UBERON:0001048!1.61e-10!168;UBERON:0003914!1.95e-10!118;UBERON:0005911!2.83e-10!82;UBERON:0000486!5.62e-10!82;UBERON:0000025!5.10e-09!194;UBERON:0000062!6.51e-09!511;UBERON:0003929!7.07e-09!54;UBERON:0000948!7.43e-08!24;UBERON:0005498!7.43e-08!24;UBERON:0004140!7.43e-08!24;UBERON:0009881!7.43e-08!24;UBERON:0004141!7.43e-08!24;UBERON:0003084!7.43e-08!24;UBERON:0007005!7.43e-08!24;UBERON:0004139!7.43e-08!24;UBERON:0004291!7.43e-08!24;UBERON:0007100!8.32e-08!27;UBERON:0007499!1.18e-07!25;UBERON:0003103!1.39e-07!69;UBERON:0009856!1.54e-07!26;UBERON:0005177!1.64e-07!107;UBERON:0009497!1.75e-07!25;UBERON:0000015!1.75e-07!25;UBERON:0002423!1.75e-07!25;UBERON:0006235!1.75e-07!25;UBERON:0004161!1.75e-07!25;UBERON:0005156!2.46e-07!59;UBERON:0000990!2.46e-07!59;UBERON:0000466!3.28e-07!126;UBERON:0001041!3.36e-07!98;UBERON:0008835!8.60e-07!22;UBERON:0003894!8.60e-07!22
}}
}}

Revision as of 14:12, 21 May 2012


Full id: C154_adenocarcinoma_Mesenchymal_Cardiac_small_sacrococcigeal_Smooth_Prostate



Phase1 CAGE Peaks

Hg19::chr10:118885954..118885990,-p16@KIAA1598
Hg19::chr10:14504151..14504156,-p41@FRMD4A
Hg19::chr10:20659504..20659530,+p@chr10:20659504..20659530
+
Hg19::chr10:78078088..78078092,+p6@C10orf11
Hg19::chr10:78078781..78078813,+p@chr10:78078781..78078813
+
Hg19::chr11:1853010..1853019,+p@chr11:1853010..1853019
+
Hg19::chr11:1853029..1853045,+p9@SYT8
Hg19::chr11:32418017..32418035,-p@chr11:32418017..32418035
-
Hg19::chr11:45274072..45274078,-p@chr11:45274072..45274078
-
Hg19::chr11:45274102..45274110,-p@chr11:45274102..45274110
-
Hg19::chr11:64068136..64068191,+p2@C11orf20
Hg19::chr11:64068193..64068201,+p4@C11orf20
Hg19::chr11:74203338..74203363,+p@chr11:74203338..74203363
+
Hg19::chr12:116356689..116356694,-p@chr12:116356689..116356694
-
Hg19::chr12:127841607..127841612,-p@chr12:127841607..127841612
-
Hg19::chr12:130554803..130554831,+p1@ENST00000535487
Hg19::chr12:4067801..4067810,-p@chr12:4067801..4067810
-
Hg19::chr12:51422113..51422122,-p13@SLC11A2
Hg19::chr13:23993097..23993108,+p1@SACS-AS1
Hg19::chr14:46185170..46185184,-p1@ENST00000555442
Hg19::chr15:66874502..66874507,+p1@ENST00000558797
p1@uc002aqe.2
Hg19::chr15:79550146..79550153,+p@chr15:79550146..79550153
+
Hg19::chr16:49601912..49601949,-p@chr16:49601912..49601949
-
Hg19::chr16:68415381..68415397,-p@chr16:68415381..68415397
-
Hg19::chr16:68415402..68415427,-p@chr16:68415402..68415427
-
Hg19::chr17:41319358..41319362,-p@chr17:41319358..41319362
-
Hg19::chr17:7945494..7945505,+p@chr17:7945494..7945505
+
Hg19::chr17:7945517..7945524,+p@chr17:7945517..7945524
+
Hg19::chr18:19664761..19664775,+p@chr18:19664761..19664775
+
Hg19::chr18:55562609..55562633,-p@chr18:55562609..55562633
-
Hg19::chr19:14911558..14911572,-p@chr19:14911558..14911572
-
Hg19::chr19:35298485..35298515,-p@chr19:35298485..35298515
-
Hg19::chr19:40729176..40729179,-p@chr19:40729176..40729179
-
Hg19::chr19:6573965..6573973,-p@chr19:6573965..6573973
-
Hg19::chr1:171183141..171183168,-p@chr1:171183141..171183168
-
Hg19::chr1:20509818..20509830,+p@chr1:20509818..20509830
+
Hg19::chr1:210730983..210730994,-p@chr1:210730983..210730994
-
Hg19::chr1:229972086..229972113,-p@chr1:229972086..229972113
-
Hg19::chr1:53925063..53925076,+p2@DMRTB1
Hg19::chr1:53925386..53925397,+p4@DMRTB1
Hg19::chr1:53926206..53926223,+p@chr1:53926206..53926223
+
Hg19::chr1:66713214..66713221,+p@chr1:66713214..66713221
+
Hg19::chr1:6784296..6784306,-p@chr1:6784296..6784306
-
Hg19::chr21:45232916..45232945,-p5@LOC284837
Hg19::chr22:32009392..32009402,+p14@SFI1
Hg19::chr22:32009407..32009413,+p17@SFI1
Hg19::chr22:40289822..40289826,+p@chr22:40289822..40289826
+
Hg19::chr22:48786318..48786324,-p@chr22:48786318..48786324
-
Hg19::chr2:101855021..101855022,+p@chr2:101855021..101855022
+
Hg19::chr2:108856421..108856429,+p@chr2:108856421..108856429
+
Hg19::chr2:108905228..108905241,+p5@SULT1C2
Hg19::chr2:108932073..108932081,-p@chr2:108932073..108932081
-
Hg19::chr2:11720189..11720191,-p@chr2:11720189..11720191
-
Hg19::chr2:145425540..145425556,+p1@ENST00000431734
p1@ENST00000445791
p1@ENST00000451027
p1@uc002twc.2
Hg19::chr2:160522..160528,-p@chr2:160522..160528
-
Hg19::chr2:178509557..178509590,+p@chr2:178509557..178509590
+
Hg19::chr2:33208767..33208789,+p@chr2:33208767..33208789
+
Hg19::chr3:106851639..106851650,-p@chr3:106851639..106851650
-
Hg19::chr3:20422728..20422736,+p@chr3:20422728..20422736
+
Hg19::chr4:17654780..17654789,-p@chr4:17654780..17654789
-
Hg19::chr4:185269961..185269964,-p@chr4:185269961..185269964
-
Hg19::chr4:2038237..2038246,+p@chr4:2038237..2038246
+
Hg19::chr4:27079602..27079607,+p@chr4:27079602..27079607
+
Hg19::chr4:56683266..56683270,+p@chr4:56683266..56683270
+
Hg19::chr4:87587967..87588007,+p@chr4:87587967..87588007
+
Hg19::chr5:108342105..108342113,+p@chr5:108342105..108342113
+
Hg19::chr5:127132..127168,+p@chr5:127132..127168
+
Hg19::chr5:133842199..133842211,+p2@ENST00000515627
Hg19::chr5:180455151..180455156,-p@chr5:180455151..180455156
-
Hg19::chr5:33297946..33297962,-p1@ENST00000510327
Hg19::chr5:92899690..92899725,-p@chr5:92899690..92899725
-
Hg19::chr6:30899924..30899954,-p1@SFTA2
Hg19::chr6:30899962..30899981,-p3@SFTA2
Hg19::chr6:32185040..32185049,-p@chr6:32185040..32185049
-
Hg19::chr6:32185064..32185097,+p@chr6:32185064..32185097
+
Hg19::chr6:32186154..32186158,-p@chr6:32186154..32186158
-
Hg19::chr6:39909704..39909749,+p@chr6:39909704..39909749
+
Hg19::chr7:128481478..128481523,+p7@FLNC
Hg19::chr7:138414274..138414282,-p@chr7:138414274..138414282
-
Hg19::chr7:138414322..138414330,-p@chr7:138414322..138414330
-
Hg19::chr7:1516517..1516531,-p@chr7:1516517..1516531
-
Hg19::chr7:155754053..155754062,+p@chr7:155754053..155754062
+
Hg19::chr7:34697812..34697844,+p1@NPSR1
Hg19::chr7:34697846..34697874,+p2@NPSR1
Hg19::chr7:34890932..34890934,+p@chr7:34890932..34890934
+
Hg19::chr7:44233871..44233878,+p@chr7:44233871..44233878
+
Hg19::chr7:81399329..81399345,-p3@HGF
Hg19::chr7:81399355..81399373,-p1@HGF
Hg19::chr7:81399905..81399916,-p13@HGF
Hg19::chr7:81500953..81500994,+p@chr7:81500953..81500994
+
Hg19::chr7:81631574..81631599,+p@chr7:81631574..81631599
+
Hg19::chr7:95115174..95115187,+p2@ASB4
Hg19::chr7:95115210..95115217,+p3@ASB4
Hg19::chr8:144822864..144822887,-p@chr8:144822864..144822887
-
Hg19::chr8:19930258..19930259,-p@chr8:19930258..19930259
-
Hg19::chr8:28102617..28102623,-p@chr8:28102617..28102623
-
Hg19::chr8:60149243..60149248,-p@chr8:60149243..60149248
-
Hg19::chr8:60441483..60441488,+p@chr8:60441483..60441488
+
Hg19::chr8:60441494..60441507,+p@chr8:60441494..60441507
+
Hg19::chr8:82351669..82351674,+p3@ENST00000524085
Hg19::chr9:139259676..139259683,-p@chr9:139259676..139259683
-
Hg19::chrX:31090138..31090151,-p2@FTHL17
Hg19::chrX:31090152..31090184,-p1@FTHL17
Hg19::chrX:41887620..41887656,+p@chrX:41887620..41887656
+
Hg19::chrX:43036245..43036248,+p1@ENST00000440955
p1@uc004dfw.1
Hg19::chrX:49460578..49460597,-p1@PAGE1
Hg19::chrX:49460603..49460612,-p2@PAGE1
Hg19::chrX:52572878..52572895,+p@chrX:52572878..52572895
+
Hg19::chrX:55101450..55101482,+p1@PAGE2B
Hg19::chrX:55101495..55101519,+p2@PAGE2B
Hg19::chrX:70886748..70886757,-p@chrX:70886748..70886757
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006826iron ion transport0.031978858554635



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
multi-tissue structure2.22e-26347
mesenchyme4.85e-23238
entire embryonic mesenchyme4.85e-23238
trunk mesenchyme2.42e-20143
trunk8.74e-19216
digestive system4.40e-16155
digestive tract4.40e-16155
primitive gut4.40e-16155
endoderm-derived structure1.68e-15169
endoderm1.68e-15169
presumptive endoderm1.68e-15169
muscle tissue7.85e-1463
musculature7.85e-1463
musculature of body7.85e-1463
somite7.88e-1483
paraxial mesoderm7.88e-1483
presomitic mesoderm7.88e-1483
presumptive segmental plate7.88e-1483
trunk paraxial mesoderm7.88e-1483
presumptive paraxial mesoderm7.88e-1483
anatomical cluster1.09e-13286
embryo1.77e-13612
skeletal muscle tissue6.18e-1361
striated muscle tissue6.18e-1361
myotome6.18e-1361
subdivision of digestive tract9.19e-13129
endodermal part of digestive tract9.19e-13129
unilaminar epithelium9.85e-13138
dermomyotome1.04e-1270
epithelium1.17e-12309
embryonic structure1.54e-12605
developing anatomical structure1.54e-12605
cell layer3.20e-12312
germ layer3.58e-12604
embryonic tissue3.58e-12604
presumptive structure3.58e-12604
epiblast (generic)3.58e-12604
multi-cellular organism4.21e-12659
organism subdivision5.20e-12365
mesoderm8.52e-12448
mesoderm-derived structure8.52e-12448
presumptive mesoderm8.52e-12448
mixed endoderm/mesoderm-derived structure1.45e-11130
anatomical group5.51e-11626
anatomical conduit8.27e-11241
anatomical system1.00e-10625
primordium1.61e-10168
epithelial tube1.95e-10118
endo-epithelium2.83e-1082
multilaminar epithelium5.62e-1082
tube5.10e-09194
organ6.51e-09511
gut epithelium7.07e-0954
heart7.43e-0824
primitive heart tube7.43e-0824
primary heart field7.43e-0824
anterior lateral plate mesoderm7.43e-0824
heart tube7.43e-0824
heart primordium7.43e-0824
cardiac mesoderm7.43e-0824
cardiogenic plate7.43e-0824
heart rudiment7.43e-0824
primary circulatory organ8.32e-0827
epithelial sac1.18e-0725
compound organ1.39e-0769
sac1.54e-0726
trunk region element1.64e-07107
epithelium of foregut-midgut junction1.75e-0725
anatomical boundary1.75e-0725
hepatobiliary system1.75e-0725
foregut-midgut junction1.75e-0725
septum transversum1.75e-0725
reproductive structure2.46e-0759
reproductive system2.46e-0759
immaterial anatomical entity3.28e-07126
foregut3.36e-0798
hepatic diverticulum8.60e-0722
liver primordium8.60e-0722


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.